October 16, 2026

Edesa Biotech gains FDA clearance to expand Phase 2 vitiligo trial – Mugglehead Investment Magazine

October 16, 2026

EB06 Phase 2 Vitiligo Study Receives FDA IND Clearance – Dermatology Times

October 12, 2026

Clinicians Weigh Vitiligo Treatment Strategies Across Age Groups – Dermatology Times

October 11, 2026

Experts urge earlier JAK inhibitor use in AD and vitiligo | Fall Clinical Derm 2026 – Managed Healthcare Executive

October 7, 2026

Selective Oral JAK/TEK Inhibitor Effective in Phase 3 Vitiligo Trial – Medscape